Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05759143 · ClinicalTrials.gov registry record · NA
Enhancing Information Management for Young Adults After Genetic Cancer Risk Testing
A NA study of Genetic Predisposition and Genetic Predisposition to Disease, sponsored by Dana-Farber Cancer Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT05759143 is a NA study of Genetic Predisposition and Genetic Predisposition to Disease that is actively recruiting participants, run by Dana-Farber Cancer Institute. The registered enrollment target is 40 participants, below the 3,517-participant average among 14 other Genetic Predisposition trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05759143, a NA study of Genetic Predisposition and Genetic Predisposition to Disease, is actively recruiting participants, sponsored by Dana-Farber Cancer Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This research is being done to develop the electronic platform Nest for young adults (ages 18-39) who have had prior cancer genetic testing. The platform will give patients and their clinicians access to continuously updated information about both pathogenic variants and variants of uncertain significance (VUS). The name of the intervention used in this research study is: Nest portal (electronic platform for patients and clinicians)
Conditions Studied
Interventions
- BEHAVIORAL Nest Platform
Study Locations (1)
Massachusetts
- Dana Farber Cancer Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2026-07-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05759143
The ClinicalTrials.gov registry entry for NCT05759143 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,517-participant average among 14 other Genetic Predisposition trials with a reported enrollment target (99% lower). The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Genetic Predisposition appearing as the primary indexed condition, and to 1 intervention - of which Nest Platform is the first listed.
NCT05759143 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05759143 about?
NCT05759143 is a clinical study titled "Enhancing Information Management for Young Adults After Genetic Cancer Risk Testing". This research is being done to develop the electronic platform Nest for young adults (ages 18-39) who have had prior cancer genetic testing. The platform will give patients and their clinicians access to continuously updated information about both pathogenic variants and variants of uncertain signif...
What is the current status of trial NCT05759143?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2023-05-01. Estimated completion is 2026-07-30.
What conditions does trial NCT05759143 study?
This clinical trial studies the following conditions: Genetic Predisposition, Genetic Predisposition to Disease.
What interventions are being tested in trial NCT05759143?
The interventions under investigation include: Nest Platform (BEHAVIORAL).
Who is sponsoring clinical trial NCT05759143?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05759143 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Genetic Predisposition
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Using the EHR to Advance Genomic Medicine Across a Diverse Health System
RECRUITING · NA
-
Genetic Information Assistant in Telegenetics
RECRUITING · NA
-
Effectiveness of MyCancerGene to Optimize Genetic Testing Outcomes
ACTIVE NOT RECRUITING · NA
-
Overcoming Barriers to Accessing Genetic Medicine
ACTIVE NOT RECRUITING · NA
-
Early Detection of GEnetic Risk (EDGE)
COMPLETED · NA
-
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
RECRUITING
Explore more on PlainTrial
Genetic Predisposition
All registered trials for this condition
Genetic Predisposition to Disease
All registered trials for this condition
Massachusetts
All trials with a study site in Massachusetts
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.